Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120913
Status:
COMPLETED
Last Update Posted:
2005-07-19
First Post:
2005-07-12
Brief Title:
Continuous Oral Contraceptives COCs Are Bleeding Patterns Dependent on the Hormones Given
Sponsor:
Oregon Health and Science University
Organization:
Oregon Health and Science University
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2005-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
While there may be a decrease in the total number of bleeding days women experience with continuous-dosed COCs no menstrual withdrawal week these regimens frequently result in an increased number of breakthrough or non-scheduled bleeding days Breakthrough bleeding is among the main reasons cited for discontinuation of combined COCs dosed traditionally 3 weeks of active pill 1 week of placebo or continuously and may offset the perceived benefit of fewer withdrawal bleeding events for many women taking continuous-dosed COCs The exact mechanisms responsible for breakthrough bleeding patterns during hormonal contraception are unknown and may be related to the pill formulation This study is to determine whether progestin type or estrogen dose influences bleeding patterns side effects or satisfaction with combined oral contraceptives COC dosed continuously
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None